However, PI4KA inhibition does not affect the final replication yield during enterovirus infection (28, –, 30), suggesting that ER-derived ROs may confer a small benefit early in infection but are ultimately expendable for replication. This evidence concerns the gene PI4KA and enterovirus infectious disease.